Register Cart 0

Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe

Commentary

Commentary: Endophenotypes as Disease Modifiers: Decoding the Biology of Alzheimer’s by Genome-wide Association Studies

Author(s): A.R. Neelakandan and G.K. Rajanikant*

Volume 17, Issue 1, 2018

Page: [6 - 8] Pages: 3

DOI: 10.2174/1871527317666180213143832

« Previous

Rights & Permissions Print Cite

Article Metrics

38

3

1

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Nanotechnology for Alzheimer Disease
Current Alzheimer Research

Azathioprine in Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry

The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Current Drug Targets

Gender Bias in Acute Coronary Syndromes
Current Vascular Pharmacology

Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy

Zinc as an Appetite Stimulator - The Possible Role of Zinc in the Progression of Diseases Such as Cachexia and Sarcopenia
Recent Patents on Food, Nutrition & Agriculture

<i>Lactobacillus Rhamnosus</i> UBLR-58 and Diclofenac Potentiate the Anti- Alzheimer Activity of Curcumin in Mice
Current Enzyme Inhibition

Effect of Aging on Metabolic Pathways in Endothelial Progenitor Cells
Current Pharmaceutical Design

EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes
Current Neurovascular Research

Molecular Mechanisms of Bioprotection Process by Trehalose
Current Nutrition & Food Science

Drug Treatment of Trichotillomania (Hair-Pulling Disorder), Excoriation (Skin-picking) Disorder, and Nail-biting (Onychophagia)
Current Neuropharmacology

subject Index To Volume 1
Current Medicinal Chemistry - Central Nervous System Agents

Leflunomide, a Reversible Monoamine Oxidase Inhibitor
Central Nervous System Agents in Medicinal Chemistry

Meet Our Editorial Board Member
Current Psychiatry Reviews

Novel Insights for Multiple Sclerosis and Demyelinating Disorders with Apoptosis, Autophagy, FoxO, and mTOR
Current Neurovascular Research

Combination Treatment in Alzheimers Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil
Current Alzheimer Research

Amino Acid Degrading Enzymes and their Application in Cancer Therapy
Current Medicinal Chemistry

TRPV1 Function in Health and Disease
Current Pharmaceutical Biotechnology

Aluminum Excytotoxicity and NeuroAutotoImmunity: The Role of the Brain Expression of CD32+ (FcγRIIa), ICAM-1+ and CD3ع in Aging
Current Aging Science

Design, Synthesis and Biological Activity of New Polyenolic Inhibitors of Matrix Metalloproteinases: A Focus on Chemically-Modified Curcumins
Current Medicinal Chemistry

© 2025 Bentham Science Publishers | Privacy Policy